VVOS - Vivos Therapeutics GAAP EPS of -$1.63 revenue of $3.4M May, 15 2024 10:43 AM Vivos Therapeutics Inc. 2024-05-15 10:43:10 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therapeutics For further details see: Vivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4M